Clinical Trial Update: RCT Comparing 19Ga vs 22Ga EBUS-TBNA Needles in Carcinoma. [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing 19-gauge versus 22-gauge EBUS-TBNA needles in lung cancer; the study's status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: KU Leuven | Conditions: Lung Neoplasm | Phase 3 | Status: UNKNOWN